Authors:
Cousens, S
Smith, PG
Ward, H
Everington, D
Knight, RSG
Zeidler, M
Stewart, G
Smith-Bathgate, EAB
Macleod, MA
Mackenzie, J
Will, RG
Citation: S. Cousens et al., Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994-2000, LANCET, 357(9261), 2001, pp. 1002-1007
Authors:
Green, AJE
Knight, RSG
Macleod, MA
Lowman, A
Will, RG
Citation: Aje. Green et al., Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease, NEUROLOGY, 56(7), 2001, pp. 986-986
Authors:
Green, AJE
Thompson, EJ
Stewart, GE
Zeidler, M
McKenzie, JM
MacLeod, MA
Ironside, JW
Will, RG
Knight, RSG
Citation: Aje. Green et al., Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis ofvariant Creutzfeldt-Jakob disease, J NE NE PSY, 70(6), 2001, pp. 744-748
Authors:
Zerr, I
Pocchiari, M
Collins, S
Brandel, JP
Cuesta, JD
Knight, RSG
Bernheimer, H
Cardone, F
Delasnerie-Laupretre, N
Corrales, NC
Ladogana, A
Bodemer, M
Fletcher, A
Awan, T
Bremon, AR
Budka, H
Laplanche, JL
Will, RG
Poser, S
Citation: I. Zerr et al., Analysis of EEG and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease, NEUROLOGY, 55(6), 2000, pp. 811-815